• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Sanofi

Sanofi to provide COVID-19 vaccine manufacturing for rival Pfizer

January 27, 2021 By Sean Whooley

Sanofi (NYSE:SNY) announced today that it entered into an agreement to support the manufacturing and supply of the Pfizer/BioNTech COVID-19 vaccine. Pfizer and BioNTech’s vaccine is one of two to receive FDA emergency use authorization in the U.S. and it also has clearance in Europe, having received both nods in December 2020. The deal between Sanofi provides BioNTech access […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Pharmaceutical Tagged With: BioNTech, coronavirus, COVID-19, COVID-19 vaccine, GlaxoSmithKline plc, Pfizer, Sanofi, Translate Bio

Sanofi to launch COVID-19 vaccine trial in Q4

October 15, 2020 By Sean Whooley

Sanofi (NYSE:SNY) and Translate Bio (NSDQ:TBIO) announced today that a Phase 1/2 clinical trial for its COVID-19 vaccine candidate is set for the fourth quarter of 2020. Preclinical results for MRT5500, the COVID-19 vaccine candidate under development by the two companies, demonstrated a favorable immune response profile against SARS-CoV-2, the virus causing coronavirus, which supports the selection […]

Filed Under: Clinical Trials, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Sanofi, Translate Bio, vaccines

What are the top COVID-19 vaccine candidates?

September 25, 2020 By Nancy Crotti

As of yesterday, five COVID-19 vaccine candidates had begun Phase 3 clinical trials as they seek to determine the safety and efficacy of their formulas. Researchers worldwide are testing 132 COVID-19 vaccine candidates, including 42 that are in clinical trials on humans and at least 92 in preclinical or animal trials, according to the New […]

Filed Under: Business/Financial News, Clinical Trials, Featured, Pharmaceutical, Research & Development Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, GlaxoSmithKline plc, Johnson & Johnson, Moderna, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Pfizer, Sanofi, U.S. Biomedical Advanced Research and Development Authority (BARDA)

Canada lining up millions of doses of COVID-19 vaccines

September 22, 2020 By Sean Whooley

Sanofi (NYSE:SNY), GlaxoSmithKline (NYSE:GSK) and Moderna (NSDQ:MRNA) have all agreed to supply Canada with a total of more than 90 million doses of a COVID-19 vaccine. Beginning in 2021, Government of Canada is set to receive up to 72 million doses of an adjuvanted COVID-19 vaccine from Sanofi and GSK, while the country also increased its confirmed […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, GlaxoSmithKline plc, Moderna, Sanofi

Drug companies agree not to release COVID-19 vaccine until it’s ready

September 8, 2020 By Sean Whooley

Executives from nine different drug companies today announced a pledge to ensure safety with a potential COVID-19 vaccine. The CEOs of AstraZeneca (NYSE:AZN), BioNTech (NSDQ:BNTX), GlaxoSmithKline (NYSE:GSK), Johnson & Johnson (NYSE:JNJ), Merck (NYSE:MRK), Moderna (NSDQ:MRNA), Novavax (NSDQ:NVAX), Pfizer (NYSE:PFE) and Sanofi (NYSE:SNY), all of whom are developing vaccine candidates, all signed the pledge, which vows to “uphold the integrity of the scientific process” […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: AstraZeneca plc, BioNTech, coronavirus, COVID-19, Donald Trump, GlaxoSmithKline plc, Johnson and Johnson, Merck, Moderna, Novavax Inc., Pfizer, Sanofi

MedTech 100 roundup: Stocks were practically unchanged last week

August 24, 2020 By Sean Whooley

Despite plenty of ups and downs coming in the stock market for the medtech industry, there was hardly any movement from week to week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.6 points at the end of last week (Aug. 21). Overall, medtech stocks saw […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bayer, Cala Health, cochlear, conformis, CureVac, Fractyl Laboratories, Johnson and Johnson, momentapharmaceuticals, Principia Biopharma, S&P, Sanofi, Stryker, Teva Pharmaceuticals

Sanofi to acquire MS drug-development partner for $3.68B

August 17, 2020 By Sean Whooley

Sanofi (NYSE:SNY) announced today that it agreed to acquire all outstanding shares of Principia Biopharma (NSDQ:PRNB) in a deal worth approximately $3.68 billion. The deal sets all outstanding shares of Principia at $100 per share, which will be acquired in cash. Sanofi and Principia both received unanimous approval from their respective boards of directors, according to […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Neurological, Pharmaceutical, Wall Street Beat Tagged With: Principia Biopharma, Sanofi

MedTech 100 roundup: Industry hits another mid-pandemic high

August 3, 2020 By Sean Whooley

Despite a minor regression week-over-week, the medtech industry’s stocks hit another milestone as the COVID-19 rebound remains in progress. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.01 points at the end of last week (July 31). Overall, medtech stocks saw a -0.3% increase from the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics, MassDevice Earnings Roundup, Research & Development, Wall Street Beat Tagged With: 3m, Baxter, Boston Scientific, coronavirus, COVID-19, Dexcom, GE Healthcare, GlaxoSmithKline plc, Hillrom, Hologic, MedTech 100 Index, Moderna, National Institutes of Health (NIH), Philips, Sanofi, Smith & Nephew, Stryker, Tandem Diabetes Care, Teleflex

GSK, Sanofi land $2.1B from feds to develop COVID-19 vaccine

July 31, 2020 By Nancy Crotti

The Trump administration has awarded Sanofi (NYSE:SNY) and GlaxoSmithKline (NYSE:GSK) a contract for up to $1.2 billion to develop, manufacture and deliver a vaccine for COVID-19, the companies announced today. The vaccine candidate is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s established pandemic adjuvant (immunity-boosting) technology. Manufacturing will take […]

Filed Under: Business/Financial News, Featured, Pharmaceutical, Research & Development Tagged With: coronavirus, COVID-19, GlaxoSmithKline plc, Sanofi

Baxter completes Seprafilm acquisition

February 18, 2020 By Danielle Kirsh

Baxter (NYSE:BAX) today said it completed the acquisition of Seprafilm Adhesion Barrier and its assets from Sanofi in a deal worth $350 million. Seprafilm is used as an adjunct to reduce the incidence, extent and severity of adhesions in pelvic and abdominal surgeries, according to the company. It is commercially available in the U.S., Japan, […]

Filed Under: Business/Financial News, Mergers & Acquisitions Tagged With: Baxter, Sanofi

FDA clears Verily Study Watch for additional capabilities

January 22, 2020 By Chris Newmarker

Verily, Google’s life science’s sister company under Alphabet (NSDQ:GOOGL), has received an FDA 510(k) clearance to include an irregular pulse monitor in its Study Watch wearable. The FDA announcement, last updated Jan. 20, did not include additional information. The agency cleared ECG capabilities on the Study Watch in January 2019. Launched in April 2017, the Study […]

Filed Under: 510(k), Clinical Trials, Digital Health, Featured, Food & Drug Administration (FDA), Patient Monitoring, Pharmaceutical, Regulatory/Compliance Tagged With: Alphabet (Google), Novartis, Otsuka Holdings, Pfizer, Sanofi, Verily

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy